RayzeBio
CA - San DiegoPharmaceutical
Focus: RayzeBio is a San Diego-based radiopharmaceutical company focused on targeted alpha and beta therapies for cancer and neurological diseases. The company operates as a pre-revenue biotech with a focused pipeline in oncology.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About RayzeBio
AI assessmentNot HiringNo open roles listed right now. Follow RayzeBio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RYZ401
GEP-NETClinical Trials (1)
NCT07165132Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1Help build intelligence for RayzeBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.